At last report total global PC costs were $2.4B. About 70% of that goes towards physician and hospital costs. Including supportive care, emergency care (e.g. obstructions, infections), radiation, and other surgery. Then subtract out chemo and other emerging therapies for 1st line patients. Maintenance therapy where appropriate. Including regular monitoring through diagnostics. Rescue therapies. Then, and only then do you get to 2nd line patients. With similar cost considerations.
So what IF Kenny could demonstrate the Kenny Wonder Treatment is good as a palliative treatment in 2nd line PC? Patient feels good for 3 months due to less of a metastatic tumor load, and then dies. Maybe $10M/yr. The dream is that some large Pharma is going to pay $2.4B or $1/shr? Well, in that case it will only take the acquirer 240 yrs to break even. Yeah, that's the ticket! LOL